ニトレンジピン
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2012/10/22 13:38:13」(JST)
[Wiki en表示]
Nitrendipine
|
| Systematic (IUPAC) name |
| (RS)-ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
| Clinical data |
| AHFS/Drugs.com |
International Drug Names |
| MedlinePlus |
a600042 |
| Pregnancy cat. |
? |
| Legal status |
? |
| Identifiers |
| CAS number |
39562-70-4 Y |
| ATC code |
C08CA08 |
| PubChem |
CID 4507 |
| IUPHAR ligand |
2334 |
| DrugBank |
DB01054 |
| ChemSpider |
4351 Y |
| UNII |
9B627AW319 Y |
| KEGG |
D00629 Y |
| ChEMBL |
CHEMBL475534 Y |
| Chemical data |
| Formula |
C18H20N2O6 |
| Mol. mass |
360.361 g/mol |
SMILES
- O=C(OCC)\C1=C(\N/C(=C(/C(=O)OC)C1c2cccc([N+]([O-])=O)c2)C)C
|
InChI
-
InChI=1S/C18H20N2O6/c1-5-26-18(22)15-11(3)19-10(2)14(17(21)25-4)16(15)12-7-6-8-13(9-12)20(23)24/h6-9,16,19H,5H2,1-4H3 Y
Key:PVHUJELLJLJGLN-UHFFFAOYSA-N Y
|
Y (what is this?) (verify)
|
Nitrendipine is a dihydropyridine calcium channel blocker. It is used in the treatment of primary (essential) hypertension to decrease blood pressure.
|
Contents
- 1 Molecular Problem
- 2 Nature of the Treatment
- 3 Mechanism of Action
- 4 References
|
Molecular Problem
Hypertension is the chronic condition where the blood pressure is elevated beyond normal levels that vary among individuals. The elevated levels in blood pressure increases the systemic vascular pressure, which increases the workload of the heart. The mechanical stress on the heart initiates a protein cascade involving G-proteins, cyclic-AMP and PKA that result in activation of genes that produce more cardiac muscle cells.[1] The increase stress on the heart causes the heart to enlarge to accommodate the workload. However, the enlarged heart also needs structural support, which is why it produces scarring.[2] The enlargement of the heart can make it hard for some cells to get nutrients because they are too distant from the blood vessels. Also, scarring can interfere with the electrical signals that cause the heart to contract and it also limits the ability of the heart to contract and relax. In both cases there is an increase risk of heart failure.
Nature of the Treatment
Nitrendipine is given to hypertensive individuals in 20 mg oral tablets every day.[3] This amount is effective in reducing blood pressure by 15-20% within 1–2 hours of administration [3]. With long-term treatments, the dosage may rise to as much as 40 mg/day; in elderly individuals, a lower dosage of up to 5 mg/day may be equally effective (this reduction in drug amount is attributed to decreased liver function or “first pass” metabolism) [3]. Once digested, Nitrendipine is absorbed into the blood and binds to plasma proteins. The majority (98%) is bound to plasma proteins and 70-80% of its inactive polar metabolites are also bound to plasma proteins [3]. Following hepatic metabolism, 80% of the 20 mg dose can be recovered in the first 96 hours as inactive polar metabolites. The specific volume of distribution of the drug is 2-6 L/kg. In terms of drug half-life, Nitrendipine has a half-life of 12–24 hours [3]. The reported side effects include: headache, flushing, edema and palpitations. These side effects can all be attributed to the vasodilation effect of this drug [3].
Mechanism of Action
Once Nitrendipine is ingested, it is absorbed by the gut and metabolized by the liver before it goes into the systemic circulation and reaches the cells of the smooth muscles and cardiac muscle cells. It binds more effectively with L-type calcium channels in smooth muscle cells because of its lower resting membrane potential.[4] The Nitrendipine diffuses into the membrane and binds to its high affinity binding site on the inactivated L-type calcium channel that’s located in between each of the 4 intermembrane components of the α1 subunit [4]. The exact mechanism of action of Nitrendipine is unknown, but it is believed to have important Tyrosine and Threonine residues in its binding pocket and its binding interferes with the voltage sensor and gating mechanism of the channel [4]. Thought to have a domain-interface model of binding. In hypertension, the binding of Nitrendipine causes a decrease in the probability of open L-type calcium channels and reduces the influx of calcium. The reduced levels of calcium prevent smooth muscle contraction within these muscle cells. Prevention of muscle contraction enables smooth muscle dilation. Dilation of the vasculature reduces total peripheral resistance, which decreases the workload on the heart and prevents scarring of the heart or heart failure.
References
- ^ Watson PA, 1996. Mechanical activation of signaling pathways in the cardiovascular system. Trends Cardiovasc Med. 6: 73-9
- ^ Van Bilsen M and Chien KR. (1993) Growth and hypertrophy of the heart: towards an understanding of cardiac specific and inducible gene expression. Cardiovasc Res. 27:1140-9
- ^ Asif A, Siddiqui A and Polsker GL. (2004) Fixed-Dose Combination Enalapril/Nitrendipine: A Review of its use in mild-to-moderate hypertension. Drugs. 64: 1135-48
- ^ Peterson BZ, Tanada TN and Catterall WA. (1996) Molecular determinants of high affinity dihydropyridine binding in the L-type calcium channels. J. Biol. Chem. 271: 5293-6
|
Channel blockers
|
|
| Calcium (Ca2+) |
|
|
| Potassium (K+) |
- 3,4-Diaminopyridine
- 4-Aminopyridine
- Amiodarone
- Bretylium
- Bunaftine
- Charybdotoxin
- Conotoxins
- Dofetilide
- Dronedarone
- E-4031
- Ibutilide
- Linopirdine
- Maurotoxin
- Nifekalant
- Paxilline
- Sotalol
- Tedisamil
- Tetraethylammonium
- Vernakalant
|
|
| Sodium (Na+) |
- Antiarrhythmics: Ajmaline
- Aprindine
- Disopyramide
- Dronedarone
- Encainide
- Flecainide
- Lidocaine
- Lorajmine
- Lorcainide
- Mexiletine
- Moricizine
- Phenytoin
- Pilsicainide
- Prajmaline
- Procainamide
- Propafenone
- Quinidine
- Sparteine
- Tocainide
- Anticonvulsants: Carbamazepine
- Eslicarbazepine acetate
- Ethotoin
- Fosphenytoin
- Licarbazepine
- Mephenytoin
- Oxcarbazepine
- Oxitriptyline
- Phenytoin
- Rufinamide
- Topiramate
- Sodium valproate
- Valnoctamide
- Valproate pivoxil
- Valproate semisodium
- Valproic acid
- Valpromide
- Diuretics: Amiloride
- Benzamil
- Triamterene
- Local anesthetics: pFBT
- Amylocaine
- Articaine
- Benzocaine
- Bupivacaine (Levobupivacaine, Ropivacaine)
- Butacaine
- Butamben
- Chloroprocaine
- Cinchocaine
- Cocaine
- Cyclomethycaine
- Dimethocaine
- Etidocaine
- Hexylcaine
- Iontocaine
- Lidocaine
- Mepivacaine
- Meprylcaine
- Metabutoxycaine
- Orthocaine
- Piperocaine
- Prilocaine
- Procaine
- Propoxycaine
- Proxymetacaine
- Risocaine
- Tetracaine
- Trimecaine
- Toxins: Conotoxins
- Neosaxitoxin
- Saxitoxin
- Tetrodotoxin
|
|
| Other |
- Uncategorized: Ethadione
- Paramethadione
- Phenacemide
- Pheneturide
- Trimethadione
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- In vitro to in vivo extrapolation and physiologically based modeling of cytochrome p450 mediated metabolism in beagle dog gut wall and liver.
- Heikkinen AT, Fowler S, Gray L, Li J, Peng Y, Yadava P, Railkar A, Parrott N.SourceFaculty of Health Sciences, School of Pharmacy, University of Eastern Finland , Kuopio, Finland.
- Molecular pharmaceutics.Mol Pharm.2013 Apr 1;10(4):1388-99. doi: 10.1021/mp300692k. Epub 2013 Mar 13.
- The beagle dog is a widely used in vivo model to guide clinical formulation development and to explore the potential for food effects. However, the results in dogs are often not directly translatable to humans. Consequently, a physiologically based modeling strategy has been proposed, using the dog
- PMID 23438212
- [All antagonists in the treatment of hypertension and prevention of CVA].
- Spinar J, Vitovec J.SourceInterní Kardiologická Klinika Lékarské Fakulty MU a FN Brno, pracovisté Bohunice, prednosta prof. MUDr Jindrich Spninar, CSc, FESC. jspinar@fnbrno.cz
- Vnitr̆ní lékar̆ství.Vnitr Lek.2013 Jan;59(1):71-8.
- All antagonists (sartans) are considered to be a group of pharmaceuticals with comparable indications and comparable effects as ACE inhibitors, while almost lacking the side effect ofa dry cough. Large clinical trials showed that All antagonists had a comparable (statistically insignificantly smalle
- PMID 23565527
- 5-FU-induced cardiac toxicity--an underestimated problem in radiooncology?
- Steger F, Hautmann MG, Kölbl O.SourceDepartment of radiotherapy, University of Regensburg, Franz-Josef-Strauss-Allee 11, Regensburg 93053, Germany. felix.steger@ukr.de
- Radiation oncology (London, England).Radiat Oncol.2012 Dec 15;7:212. doi: 10.1186/1748-717X-7-212.
- BACKGROUND: 5-Fluorouracil (5-FU) is an antimetabolite, which is frequently used as chemotherapeutic agent for combined chemoradiotherapy. The purpose of this study was to present the clinical course of three patients who developed severe cardiac toxicity by 5-FU and to give a review of the literatu
- PMID 23241239
Japanese Journal
- Ablation of the N-type calcium channel ameliorates diabetic nephropathy with improved glycemic control and reduced blood pressure
- Molecular Mechanism of the Urate-lowering Effects of Calcium Channel Blockers
- Inhibition of N-type Ca[2+] channels ameliorates an imbalance in cardiac autonomic nerve activity and prevents lethal arrhythmias in mice with heart failure.
Related Links
- View and buy high purity Nitrendipine from Tocris Bioscience, the leading worldwide supplier of high performance life science reagents ... References Merck Index 12 6667. Watanabe et al (1995) L-type calcium channel block by ...
- Nitrendipine is a dihydropyridine calcium channel blocker with an IC50 of 95 nM. Find all the information about Nitrendipine for cell signaling research. ... Veliparib (ABT-888) Veliparib (ABT-888) is a ...
Related Pictures
★リンクテーブル★
[★]
- 英
- nitrendipine
- 商
- エカテリシン、エレナール、コバテンシン、シェトラゾーナ、ダウンテンシン、ドスペロピン、ニトプレス、ニトレジック、ニトレナール、ニルジピン、バイニロード、バイロテンシン、バロジピン、バロテイン、ヒシロミン
